Published in Antimicrob Agents Chemother on June 01, 1979
Related functional domains in virus DNA polymerases. EMBO J (1987) 3.35
A new nucleoside analog, 9-[[2-hydroxy-1-(hydroxymethyl)ethoxyl]methyl]guanine, highly active in vitro against herpes simplex virus types 1 and 2. Antimicrob Agents Chemother (1982) 2.83
Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus. J Virol (1985) 2.18
Mutations in the herpes simplex virus DNA polymerase gene can confer resistance to 9-beta-D-arabinofuranosyladenine. J Virol (1982) 1.79
Susceptibility of phosphonoformic acid-resistant herpes simplex virus variants to arabinosylnucleosides and aphidicolin. Antimicrob Agents Chemother (1983) 1.20
9-(3,4-dihydroxybutyl)guanine, a new inhibitor of herpesvirus multiplication. Antimicrob Agents Chemother (1983) 1.18
Cooperative effects between two acyclovir resistance loci in herpes simplex virus. J Virol (1984) 1.01
Selective inhibition of herpesvirus deoxyribonucleic acid synthesis by acycloguanosine, 2'-fluoro-5-iodo-aracytosine, and (E)-5-(2-bromovinyl)-2'-deoxyuridine. Antimicrob Agents Chemother (1981) 0.93
Herpes simplex virus mutants resistant to arabinosyladenine in the presence of deoxycoformycin. Antimicrob Agents Chemother (1984) 0.87
Synergism among BIOLF-62, phosphonoformate, and other antiherpetic compounds. Antimicrob Agents Chemother (1982) 0.84
Recent advances in cloning herpesviral genomes as infectious bacterial artificial chromosomes. Cell Cycle (2011) 0.75
Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells. J Gen Virol (1968) 26.67
Nonstructural proteins of herpes simplex virus. I. Purification of the induced DNA polymerase. J Virol (1977) 3.57
Herpes simplex virus resistance and sensitivity to phosphonoacetic acid. J Virol (1977) 3.32
DNA-dependent DNA polymerases from HeLa cell nuclei. II. Template and substrate utilization. Biochem Biophys Res Commun (1971) 3.13
Mechanism of phosphonoacetate inhibition of herpesvirus-induced DNA polymerase. Biochemistry (1976) 2.75
Genetics of resistance to phosphonoacetic acid in strain KOS of herpes simplex virus type 1. J Virol (1977) 2.71
Trisodium phosphonoformate, a new antiviral compound. Science (1978) 2.13
CELL CULTURE STUDIES ON ANTIVIRAL AGENTS. I. ACTION OF CYTOSINE ARABINOSIDE AND SOME COMPARISONS WITH 5-IODO-2-DEOXYURIDINE. Proc Soc Exp Biol Med (1964) 1.90
Inhibition of herpesvirus replication and herpesvirus-induced deoxyribonucleic acid polymerase by phosphonoformate. Antimicrob Agents Chemother (1978) 1.84
Phosphonoacetic acid-resistant herpes simplex virus infection in hairless mice. Antimicrob Agents Chemother (1975) 1.72
Studies on herpes simplex. XI. The antiviral dynamics of 5-iodo-2-deoxyuridine in vivo. J Immunol (1965) 1.59
Therapeutic effect of trisodium phosphonoformate on cutaneous herpesvirus infection in guinea pigs. Antimicrob Agents Chemother (1978) 1.20
A working hypothesis--virus resistance development as an indicator of specific antiviral activity. Ann N Y Acad Sci (1977) 1.19
Characteristics of herpes simplex virus resistance to disodium phosphonoacetate. Intervirology (1978) 0.95
Rational design of arabinosyl nucleosides as antitumor and antiviral agents. Jpn J Antibiot (1977) 0.87
Adhesion of Escherichia coli to human uroepithelial cells in vitro. Infect Immun (1977) 5.28
Adverse reactions to nitrofurantoin. Analysis of 921 reports. Am J Med (1980) 4.03
Longer delays in tuberculosis diagnosis among women in Vietnam. Int J Tuberc Lung Dis (1999) 3.30
Long-term follow-up study of osseointegrated implants in the treatment of totally edentulous jaws. Int J Oral Maxillofac Implants (1990) 3.10
Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate. Antimicrob Agents Chemother (1977) 2.71
Adhesion to normal human uroepithelial cells of Escherichia coli from children with various forms of urinary tract infection. J Pediatr (1978) 2.60
Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology (2005) 2.49
Increase of asthma, allergic rhinitis and eczema in Swedish schoolchildren between 1979 and 1991. Clin Exp Allergy (1995) 2.49
Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center. Ann Oncol (1997) 2.46
Long-term neurological dysfunction and neonatal hypoglycaemia after diabetic pregnancy. Arch Dis Child Fetal Neonatal Ed (1998) 2.42
Adhesion of Streptococcus pneumoniae to human pharyngeal epithelial cells in vitro: differences in adhesive capacity among strains isolated from subjects with otitis media, septicemia, or meningitis or from healthy carriers. Infect Immun (1981) 2.33
Trisodium phosphonoformate, a new antiviral compound. Science (1978) 2.13
Interferon-induced enhancement of 2',5'-oligoadenylate synthetase in mid-gut carcinoid tumours. Lancet (1990) 2.04
Antiviral effects of phosphonoformate (PFA, foscarnet sodium). Pharmacol Ther (1982) 2.04
Inhibition of HTLV-III/LAV replication by foscarnet. Biochem Pharmacol (1985) 1.97
HIV-1-specific reverse transcriptase inhibitors show differential activity against HIV-1 mutant strains containing different amino acid substitutions in the reverse transcriptase. Virology (1993) 1.92
Incidence of soccer injuries and their relation to training and team success. Am J Sports Med (1983) 1.88
Does early exposure to cat or dog protect against later allergy development? Clin Exp Allergy (1999) 1.86
Real world pharmacy: assessing the quality of private pharmacy practice in the Lao People's Democratic Republic. Soc Sci Med (2001) 1.74
Identification of the in vitro translation products of adenovirus mRNA by immunoprecipitation. J Virol (1975) 1.74
Mode of action, toxicity, pharmacokinetics, and efficacy of some new antiherpesvirus guanosine analogs related to buciclovir. Antimicrob Agents Chemother (1986) 1.71
Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors. Proc Natl Acad Sci U S A (1995) 1.69
Purification of Epstein-Barr virus DNA polymerase from P3HR-1 cells. J Virol (1985) 1.66
[111In-DTPA-D-Phe1]octreotide scintigraphy in patients with carcinoid tumours: the predictive value for somatostatin analogue treatment. Eur J Endocrinol (1994) 1.61
Private pharmacy practice and regulation. A randomized trial in Lao P.D.R. Int J Technol Assess Health Care (2001) 1.61
Increased activity in left ventricular receptors during hemorrhage or occlusion of caval veins in the cat. A possible cause of the vaso-vagal reaction. Acta Physiol Scand (1972) 1.61
Effects of warming up, massage, and stretching on range of motion and muscle strength in the lower extremity. Am J Sports Med (1983) 1.58
Replication of poliovirus RNA studied by gel filtration and electrophoresis. Eur J Biochem (1969) 1.58
Biochemical and biological characteristics of carbethoxylated poliovirus and viral RNA. Biochim Biophys Acta (1970) 1.54
RNA ligase activity in phage-infected bacteria and animal cells. Eur J Biochem (1974) 1.50
Influence of cells and virus multiplicity on the inhibition of herpesviruses with acycloguanosine. Intervirology (1980) 1.50
Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowth. Int J Cancer (1987) 1.48
Postoperative confusion after anesthesia in elderly patients with femoral neck fractures. Anesth Analg (1987) 1.48
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. J Thromb Haemost (2009) 1.45
Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogs. Biochem Biophys Res Commun (1991) 1.44
Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography. J Clin Endocrinol Metab (2005) 1.40
Binding of histidine to tobacco mosaic virus RNA. Biochem Biophys Res Commun (1972) 1.40
Balloon dilation of stenotic aortic valve in children. An intraoperative study. J Thorac Cardiovasc Surg (1992) 1.40
Intra- and inter-tester reliability and reference values for hand strength. J Rehabil Med (2001) 1.37
Antiherpetic activity and mechanism of action of 9-(4-hydroxybutyl)guanine. Antiviral Res (1983) 1.35
Replicative structures of poliovirus RNA in vivo. J Mol Biol (1971) 1.35
The crystal structure of cytochrome c peroxidase. J Biol Chem (1980) 1.35
Pyrophosphate analogues as inhibitors of herpes simplex virus type 1 DNA polymerase. Biochim Biophys Acta (1980) 1.34
Pyrophosphate analogues as inhibitors of DNA polymerases of cytomegalovirus, herpes simplex virus and cellular origin. Biochim Biophys Acta (1982) 1.33
Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin. Aliment Pharmacol Ther (2005) 1.32
Marginal tissue reactions at osseointegrated titanium fixtures (I). A 3-year longitudinal prospective study. Int J Oral Maxillofac Surg (1986) 1.31
PPi analogs as inhibitors of human T-lymphotropic virus type III reverse transcriptase. Antimicrob Agents Chemother (1986) 1.30
Inhibition of the reverse transcriptase from HIV by 3'-azido-3'-deoxythymidine triphosphate and its threo analogue. Antiviral Res (1987) 1.29
The COPE index--a first stage assessment of negative impact, positive value and quality of support of caregiving in informal carers of older people. Aging Ment Health (2003) 1.28
Pancreatic neuroendocrine tumors: diagnosis with PET. Radiology (1995) 1.26
Comparison of the therapeutic effects of five antiviral agents on cutaneous herpesvirus infection in guinea pigs. Arch Virol (1978) 1.26
In vivo and in vitro synthesis of adenovirus type 2 early proteins. J Virol (1976) 1.26
Intravenous foscarnet for the treatment of severe cytomegalovirus infection in allograft recipients. Scand J Infect Dis (1985) 1.25
Primary health concept revisited: where do people seek health care in a rural area of Vietnam? Health Policy (2002) 1.24
The basic helix-loop-helix transcription factor E2-2 is involved in T lymphocyte development. Eur J Immunol (2000) 1.24
Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro- 5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)]-beta-D-pentofurano syl (TSAO) nucleoside analogues retain sensitivity to HIV-1-specific nonnucleoside inhibitors. Proc Natl Acad Sci U S A (1993) 1.24
Phosphonoformate inhibits reverse transcriptase. J Gen Virol (1979) 1.22
The effect of routine hospital care on the health of hypothermic newborn infants in Zambia. J Trop Pediatr (1995) 1.22
Marginal tissue reactions at osseointegrated titanium fixtures. (II) A cross-sectional retrospective study. Int J Oral Maxillofac Surg (1986) 1.21
Studies on left ventricular receptors, signalling in non-medullated vagal afferents. Acta Physiol Scand (1972) 1.21
Therapeutic effect of trisodium phosphonoformate on cutaneous herpesvirus infection in guinea pigs. Antimicrob Agents Chemother (1978) 1.20
Chronic recurrent multifocal osteomyelitis and pustulosis palmoplantaris. J Pediatr (1978) 1.19
The relationship between active constriction and passive recoil of the veins at various distending pressures. Acta Physiol Scand (1968) 1.19
Synthesis and characterization of the L-cysteine-glutathione mixed disulfide. Acta Chem Scand (1967) 1.19
9-(3,4-dihydroxybutyl)guanine, a new inhibitor of herpesvirus multiplication. Antimicrob Agents Chemother (1983) 1.18
Antibiotic prophylaxis in recurrent erysipelas. Infection (1994) 1.17
Randomization by group in studying the effect of drug information in primary care. Int J Epidemiol (1992) 1.16
Surgical strategy for large or malignant endocrine pancreatic tumors. World J Surg (2000) 1.16
Association of breast cancer progression with a vitamin D receptor gene polymorphism. South-East Sweden Breast Cancer Group. Cancer Res (1999) 1.15
Inhibition of cytomegalovirus late antigens by phosphonoformate. Intervirology (1980) 1.15
Doppler determination of cardiac output in infants and children: comparison with simultaneous thermodilution. Pediatr Cardiol (1987) 1.15
Lower extremity goniometric measurements: a study to determine their reliability. Arch Phys Med Rehabil (1982) 1.14
Effects of "group detailing" on the prescribing of lipid-lowering drugs: a randomized controlled trial in Swedish primary care. J Clin Epidemiol (1995) 1.13
Inhibition of human immunodeficiency virus in vitro by combinations of 3'-azido-3'-deoxythymidine and foscarnet. Antimicrob Agents Chemother (1989) 1.13
Chordoma. A clinicopathologic and prognostic study of a Swedish national series. Acta Orthop Scand (1981) 1.11
Descriptions of functioning and health and relations to a gross motor classification in adults with cerebral palsy. Disabil Rehabil (2004) 1.11
Reversible inhibition of cellular metabolism by ribavirin. Antimicrob Agents Chemother (1978) 1.11
Inhibition of varicella-zoster virus-induced DNA polymerase by a new guanosine analog, 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine triphosphate. Antimicrob Agents Chemother (1988) 1.10
Therapeutic effects of foscarnet sodium and acyclovir on cutaneous infections due to herpes simplex virus type 1 in guinea pigs. J Infect Dis (1982) 1.10
Vasoconstrictor fibre discharge to skeletal muscle, kidney, intestine and skin at varying levels of arterial baroreceptor activity in the cat. Acta Physiol Scand (1972) 1.09
Influence of twenty potentially antiviral substances on in vitro multiplication of hepatitis A virus. Antiviral Res (1986) 1.09
Purification and characterization of an early protein (E14K) from adenovirus type 2-infected cells. J Virol (1978) 1.09
Kinetic analysis in cell culture of the reversal of antiherpes activity of nucleoside analogs by thymidine. Antimicrob Agents Chemother (1983) 1.09
ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors. Neuroendocrinology (2016) 1.09
A comparison between three commercial kits for chromogranin A measurements. J Endocrinol (2003) 1.08
Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds. J Clin Endocrinol Metab (1991) 1.08
Maternal and infant health problems after normal childbirth: a randomised controlled study in Zambia. J Epidemiol Community Health (1998) 1.08
Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients. Am J Psychiatry (1999) 1.08
Randomised study of skin-to-skin versus incubator care for rewarming low-risk hypothermic neonates. Lancet (1998) 1.07
Improving drug use through continuing education: a randomized controlled trial in Zambia. J Clin Epidemiol (1996) 1.06
IgE screening in 1701 newborn infants and the development of atopic disease during infancy. Arch Dis Child (1982) 1.05
Antiviral effects of 3'-fluorothymidine and 3'-azidothymidine in cynomolgus monkeys infected with simian immunodeficiency virus. J Acquir Immune Defic Syndr (1991) 1.04
Antiherpes effects and pharmacokinetic properties of 9-(4-hydroxybutyl) guanine and the (R) and (S) enantiomers of 9-(3,4-dihydroxybutyl)guanine. Antimicrob Agents Chemother (1985) 1.04
Streptozocin and o,p'DDD in the treatment of adrenocortical cancer patients: long-term survival in its adjuvant use. Ann Oncol (2000) 1.03
Antiherpes activity of [E]-5-(1-propenyl)-2'-deoxyuridine and 5-(1-propenyl)-1-beta-D-arabinofuranosyluracil. Antiviral Res (1981) 1.02